Our current observations indicate that Celastrol supplementation-mediated AngII increased aortic MMP9 and plays a critical role in alleviating sexual dimorphism of AngII-induced AAA formation in hypercholesterolemic mice. This evidence concerns the gene AGT and triple-A syndrome.